Brief: CTI Biopharma Announces Presentation Of New Anemia Benefit Data From Pacritinib Program
21/09/2022 23:10
Sept 21 (Reuters) - CTI Biopharma Corp CTIC.O :
* CTI BIOPHARMA ANNOUNCES PRESENTATION OF NEW ANEMIA BENEFIT
DATA
FROM PACRITINIB PROGRAM AT THE SOCIETY OF HEMATOLOGIC ONCOLOGY
(SOHO) TENTH ANNUAL MEETING
Source text for Eikon: ID:nPn4qvsRta
Further company coverage: CTIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CTI Biopharma
See all newsBrief: CTI Biopharma Cancels 2023 Annual Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners